Association of liver fibrosis and hypophosphatemia in treatment-naive patients with chronic hepatitis B

被引:0
|
作者
Jiang, Suling [1 ]
Wang, Jian [2 ,3 ]
Zhu, Li [4 ]
Zhang, Zhiyi [5 ]
Zhan, Jie [1 ]
Ding, Weimao [6 ]
Li, Jie [1 ,2 ,3 ]
Zhu, Chuanwu [4 ]
Huang, Rui [1 ,2 ,3 ]
Wu, Chao [1 ,2 ,3 ]
机构
[1] Nanjing Med Univ, Nanjing Drum Tower Hosp, Clin Coll, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Infect Dis,Affiliated Hosp, Nanjing, Jiangsu, Peoples R China
[3] Nanjing Univ, Inst Viruses & Infect Dis, Nanjing, Jiangsu, Peoples R China
[4] Soochow Univ, Affiliated Infect Dis Hosp, Dept Infect Dis, Suzhou, Jiangsu, Peoples R China
[5] Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China
[6] Huaian 4 Peoples Hosp, Dept Hepatol, Huaian, Jiangsu, Peoples R China
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
WED-140
引用
收藏
页码:S1078 / S1079
页数:2
相关论文
共 50 条
  • [21] Genotyping of HBV and tracking of resistance mutations in treatment-naive patients with chronic hepatitis B
    Pacheco, Sidelcina Rugieri
    Magalhaes Andrade dos Santos, Maria Isabel
    Stocker, Andreas
    Sant'Anna Zarife, Maria Alice
    Schinoni, Maria Isabel
    Parana, Raymundo
    dos Reis, Mitermayer Galvao
    Silva, Luciano Kalabric
    INFECTION AND DRUG RESISTANCE, 2017, 10 : 201 - 207
  • [22] Accumulation of mutations in reverse transcriptase of hepatitis B virus is associated with liver disease severity in treatment-naive Chinese patients with chronic hepatitis B
    Zhu, Bin
    Wang, Tianbao
    Wei, Xiaoxia
    Zhuo, Ya
    Liu, Amin
    Zhang, Guangwen
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 26 (07): : 1123 - 1129
  • [23] Potential antiviral drug resistance mutations in patients with treatment-naive chronic hepatitis B
    Cakal, Bulent
    Cavus, Bilger
    Poda, Mehves
    Atasoy, Alp
    Bulakci, Mesut
    Gulluoglu, Mine
    Akyuz, Filiz
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2024, 15 (03): : 182 - 187
  • [24] Letter: tenofovir may be superior to entecavir for treatment-naive chronic hepatitis B patients
    Wang, Ji-Gan
    Chen, Rui
    Wang, Li-Chuan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (09) : 1048 - 1049
  • [25] ALT Levels in Treatment-Naive, Chronic Hepatitis B Patients with Concurrent Fatty Liver Disease: A US Nationwide Study
    Chang, Christine Y.
    Kam, Leslie
    Dang, Nolan
    Cheung, Ramsey
    Nguyen, Mindie H.
    DIGESTIVE DISEASES, 2022, 40 (04) : 497 - 505
  • [26] Mortality, liver transplantation and hepatic complications in patients with treatment-naive chronic hepatitis B treated with entecavir vs tenofovir
    Kim, Byung Gyu
    Park, Neung Hwa
    Lee, Seung Bum
    Lee, Hojune
    Lee, Byung Uk
    Park, Jae Ho
    Jung, Seok Won
    Jeong, In Du
    Bang, Sung-Jo
    Shin, Jung Woo
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (12) : 1565 - 1575
  • [27] Antiviral therapy for treatment-naive hepatitis B virus patients
    Lau, DTY
    Membreno, FE
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (03) : 581 - +
  • [28] A personalized approach to optimize hepatitis B treatment in treatment-naive patients
    Marcellin, Patrick
    Liang, Jake
    ANTIVIRAL THERAPY, 2010, 15 : 53 - 59
  • [29] Primary resistance to Hepatitis B Virus in the treatment-naive Patients
    Altindis, M.
    Demir, L.
    Uslan, I.
    Mehmet, Ozdemir
    Baykan, M.
    Kosecik, M.
    JOURNAL OF CLINICAL VIROLOGY, 2015, 70 : S118 - S118
  • [30] Systematic review: combination therapies for treatment-naive chronic hepatitis B
    Kumar, M.
    Sarin, S. K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (12) : 1187 - 1209